What AgaMatrix does

AgaMatrix, Inc. is a US-based medical device company founded in 2001 and headquartered in Derry, New Hampshire, that designs, manufactures, and distributes blood glucose monitoring (BGM) products for diabetes management. The company's technical foundation is its proprietary WaveSense platform, which applies Dynamic Electrochemistry algorithms to electrochemical sensor signals to produce glucose readings with clinically validated accuracy. The product portfolio comprises three core meter lines (Presto at $6.95, Jazz Wireless 2 with Bluetooth at $14.95, CareSens S Fit at $5.99), meter-locked proprietary test strips, control solutions at multiple quality levels, ultra-thin lancets, lancing devices, and bundled 3-month starter kits. The offering is extended digitally by the AgaMatrix Diabetes Manager mobile application (iOS and Android) with HIPAA-compliant cloud backup and Apple Health integration, and the Zero-Click desktop data management software that includes a professional mode for clinics managing up to 10,000 patients.

The business operates a hybrid go-to-market model. Direct-to-consumer revenue flows through the agamatrix.com e-commerce storefront with flat-rate shipping pricing. Enterprise revenue flows through channel partnerships: a global BGM co-development alliance with Sanofi since 2010 (producing iBGStar, MyStar Extra, MyStar DoseCoach, distributed in 15+ countries), an exclusive private-label manufacturing agreement with Perrigo for major retailers, a CVS Health private-label product line (CVS Health Advanced) which was awarded the Diabetes Technology Society Seal of Approval in 2018, and a 2024 exclusive UK NHS distribution deal with Digostics for gestational diabetes home-testing. Products reach end consumers through CVS Pharmacy, Meijer, Apple retail stores (where AgaMatrix was the first chemistry-based product placed), and 20,000+ additional retail points across 30+ countries.

The company is privately held and has been a subsidiary of i-SENS Korea since 2023, following a previously independent operating history that included approximately $152 million in cumulative funding across rounds from Collaborative Fund, Tank Partners, incTANK Ventures, Noble International, Prospect Capital, and Perceptive Advisors. The leadership team includes CEO Jake Cho (appointed 2023), CFO Justin Lee, Chairman Chandra Selvadurai (Managing Director of Pharmaco NZ and Australia), and Dr. Hakhyun Nam (i-SENS CEO, board director). The company holds FDA clearances for its first Dynamic Electrochemistry meter (2005) and for iPhone connectivity (2010), and earned ISDP 10003 Data Protection Certification in 2020 for GDPR-compliant cloud infrastructure.

Name

AgaMatrix

Legal name

AgaMatrix, Inc.

Website

https://agamatrix.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

251–500 employees

Short description

AgaMatrix is a Derry, New Hampshire-based medical device company that designs, manufactures, and distributes blood glucose meters, proprietary test strips, and connected diabetes management software, selling through D2C e-commerce, retail chains (CVS, Meijer, Apple), and global OEM partnerships with Sanofi, CVS Health, and Perrigo across 30+ countries. Now an i-SENS Korea subsidiary.

Ownership category

akta.pro rank

Product category

Blood Glucose Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG)

akta.pro secondary industry

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)

Keywords

• Blood glucose monitoring
• Diabetes testing supplies
• Glucose meters and strips
• Diabetes care devices
• Medical device manufacturing

Headquarters

HQ city

Salem

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Blood Glucose Meters: Sale of glucose monitoring devices including Presto ($6.95), Jazz Wireless 2 ($14.95), and CareSens S Fit. One-time hardware sales with multi-year device lifespan.
2. Test Strips and Consumables: Recurring revenue from test strips (Presto, Jazz, CareSens), lancets, control solutions, and lancing devices. Consumables purchased regularly by diabetes patients.
3. Private Label / OEM Licensing: Partnership with Perrigo to produce and distribute private-label meters for major retailers, and collaboration with Sanofi on co-branded products like iBGStar, MyStar Extra, and MyStar DoseCoach.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels4 records

Core offering

AgaMatrix develops, manufactures, and sells blood glucose monitoring systems and diabetes testing supplies for individual diabetes management. Its core product lines include the Presto, Jazz Wireless 2 (Bluetooth-enabled), and CareSens S Fit glucose meters, paired with proprietary test strips, control solutions, lancets, and lancing devices. The portfolio is extended by the AgaMatrix Diabetes Manager mobile app and Zero-Click desktop software that enable connected health tracking and clinical data management.

Product overview

AgaMatrix offers a comprehensive blood glucose monitoring ecosystem comprising three core glucose meter product lines (Presto, Jazz Wireless 2, and CareSens S Fit), proprietary consumable test strips, quality control solutions, and lancing devices. The portfolio is complemented by two software platforms: the AgaMatrix Diabetes Manager mobile app (iOS/Android) for wireless Bluetooth syncing and connected health tracking, and Zero-Click Data Management Software for desktop-based diabetes data management. The Jazz Wireless 2 serves as the flagship connected product enabling automatic data sync to the mobile app, while Presto and CareSens S Fit address entry-level and value-segment needs. Supporting products include control solutions at multiple levels, ultra-thin lancets, and bundled starter kits providing 3-month supply packs.

Differentiator

Problem solved

Functional benefit

Brands

• CVS Health Advanced: Private-label blood glucose meters and test strips available at CVS Pharmacy retail stores, built on AgaMatrix's proven technology.
• Zero-Click
• Jazz Wireless
• Presto
• CareSens S Fit

Products and services

• AgaMatrix Presto Blood Glucose Monitoring System Entry-level blood glucose monitoring system for everyday diabetes self-monitoring. Features proven WaveSense accuracy, fast 5-second results, large backlit display, and stores up to 300 results. Used with AgaMatrix Presto Test Strips. Priced at $6.95.
• Jazz Wireless 2 Blood Glucose Monitoring System Bluetooth-enabled connected blood glucose monitoring system for diabetes management. Features automatic wireless syncing to the AgaMatrix Diabetes Manager mobile app, 0.5 µL sample size, 5-second results, and tracks glucose, carb, insulin, and weight data. Used with Jazz Test Strips. Priced at $14.95.
• CareSens S Fit Blood Glucose Monitoring System Simple, reliable blood glucose meter for everyday diabetes testing. Features proven accuracy, 6-second test time, 0.5 µL sample size, large easy-to-read display, and stores up to 1000 results. Use only with CareSens S Fit Test Strips. Priced at $5.99 (sale) / $9.99 (regular).
• AgaMatrix Presto Test Strips (50 count) Test strips for use with AgaMatrix Presto and Presto Pro blood glucose monitoring systems, providing accurate and reliable results across wide operating conditions. Recurring consumable revenue product at $11.95 per vial of 50 strips.
• AgaMatrix Jazz Test Strips (50 count) Quick-filling test strips for use with the Jazz Wireless 2 blood glucose monitoring system, providing accurate results in 5 seconds with proven clinical accuracy and no coding required. Priced at $11.95 per 50-count vial.
• CareSens S Fit Test Strips (50 count) Test strips for use with CareSens S Fit Blood Glucose Monitoring Systems, providing accurate results with small 0.5 µL sample size. Recurring consumable product sold in 50-count vials.
• AgaMatrix Control Solutions (Level 2 and Level 4 for Jazz; Normal and High for Presto) Quality control solutions for AgaMatrix blood glucose monitoring systems. Level 2 and Level 4 solutions are for the Jazz Wireless 2 system, while Normal and High solutions are for Presto and Presto Pro systems. Used in clinical and professional settings to confirm proper meter and test strip functionality. Priced at $5.99 each.
• AgaMatrix Ultra-Thin Lancets (33G, 100 count) Ultra-thin 33-gauge sterile single-use lancets for blood glucose testing. Thinnest lancets available from AgaMatrix, designed for maximum patient comfort. Pack of 100 lancets priced at $3.75.
• AgaMatrix Lancing Device Compact lancing device with 8 adjustable depth settings for personalized patient comfort. Compatible with AgaMatrix Ultra-Thin Lancets (33 Gauge). Used together with AgaMatrix lancets for blood sample collection in glucose testing.
• AgaMatrix Diabetes Manager (Mobile App) Free mobile app for iOS and Android enabling wireless Bluetooth syncing from the Jazz Wireless 2 meter. Tracks glucose, insulin, carbs, and weight; provides automatic HIPAA-compliant cloud backup; supports real-time sharing with family or healthcare providers; and integrates with Apple Health.
• Zero-Click Data Management Software Desktop diabetes data management software that transfers glucose readings from compatible AgaMatrix meters via USB-style cable. Features logbook view, mealtime averages, target range analysis, trend reports, and a professional mode supporting up to 10,000 patients for clinical use.

Quantifiable outcome

• 97% of results within ±15% or ±15 mg/dl of the lab reference in >95% of trials
• +1 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Six partnerships are on record, tiered regional, flagship, notable and core.

• DigosticsregionalChannel Partner/ Reseller/ Distributor · 1 April 2024In April 2024, UK-based diabetes home-testing company Digostics partnered with AgaMatrix Europe to exclusively distribute Digostics' home oral glucose tolerance testing service within the UK National Health Service, aiming to expand convenient home-based gestational diabetes screening.
• i-SENSflagshipOthers · 1 January 2023In 2023, AgaMatrix became part of i-SENS Korea - a longtime strategic partner - marking a new era of innovation and growth. i-SENS is a global leader in the development of glucose sensor devices, and AgaMatrix's CEO Jake Cho is a board member of CoaguSense (related i-SENS company).
• ApplenotableChannel Partner/ Reseller/ Distributor · 1 January 2020AgaMatrix was the first chemistry-based products to be available in Apple's retail stores, demonstrating product quality and consumer appeal.
• GlyteccoreTechnology or Integration · 1 January 2017Partnered with Glytec to deliver accurate glucose data for automated insulin titration platforms, integrating AgaMatrix's accurate glucose monitoring with Glytec's insulin management software.
• PerrigocoreOEM/ Whitelabel/ Licensing Partner · 1 January 2011Formed an exclusive agreement with Perrigo to produce and distribute private-label meters for major retailers, enabling AgaMatrix technology to reach consumers through multiple retail brands.
• SanoficoreStrategic or Co-development Partner · 1 January 2010In 2010, AgaMatrix became Sanofi's global blood glucose monitoring partner, co-developing a portfolio of innovative meters powered by WaveSense technology. Highlights include the first glucose meter to directly connect to iPhone (iBGStar), the first self-monitoring device to provide estimated A1C values (MyStar Extra), and the first meter with integrated basal insulin titration support (MyStar DoseCoach). Products developed through this partnership have been distributed in more than 15 countries.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• LifeScan: LifeScan (OneTouch brand) is a direct BGM peer offering blood glucose meters and test strips globally, including connected meter lines. It competes head-to-head with AgaMatrix in retail pharmacy and direct-to-consumer channels serving Type 1 and Type 2 diabetes patients.
• Ascensia Diabetes Care: Ascensia (Contour brand, formerly Bayer Diabetes Care) is a direct BGM peer with global retail pharmacy distribution and a portfolio of connected meters (Contour Next One, Contour Plus). Highly comparable to AgaMatrix on product format, channel strategy, and target patient segments.
• Trividia Health: Trividia Health (TRUE METRIX, TRUEresult, formerly Nipro Diagnostics) is a direct BGM peer with strong U.S. retail and mail-order presence and a focus on affordable, accurate meters. Closely comparable to AgaMatrix's value-tier Presto and CareSens offerings and channel mix.
• ARKRAY: ARKRAY (GLUCOCARD, AUTION) is a Japan-based BGM manufacturer with global distribution through pharmacy and medical channels. Comparable to AgaMatrix on BGM meter and strip product mix, channel strategy, and emphasis on clinical-grade accuracy.
• Prodigy Diabetes Care: Prodigy Diabetes Care is a U.S. BGM specialist focused on affordable voice-enabled meters for the visually impaired and value-tier segments. Closely comparable to AgaMatrix's Presto and CareSens value-tier offerings and DME/retail channel approach.

Broad incumbents

• Roche Diabetes Care: Roche Diabetes Care (Accu-Chek brand) is a broad incumbent with a global BGM portfolio spanning meters, strips, insulin pumps, and digital diabetes management. Highly comparable on product category and patient base, with materially larger scale and broader clinical/regulatory footprint.
• Abbott Diabetes Care: Abbott Diabetes Care operates the FreeStyle Libre CGM franchise plus legacy FreeStyle BGM lines, making it a broad incumbent that overlaps with AgaMatrix in BGM and is the leading disruptive force pushing the market from BGM to CGM. Directly comparable on patient base and pharmacy channel.
• Dexcom: Dexcom is a global CGM incumbent (G6, G7) whose adoption among Type 1 and insulin-using Type 2 patients is the primary secular driver of BGM unit decline. Comparable patient base and pharmacy channel; represents the structural headwind shaping AgaMatrix's BGM-focused portfolio.

Emerging players

• i-SENS: i-SENS is AgaMatrix's Korean parent company and a global leader in glucose sensor devices, marketing the CareSens BGM line and CGM sensor products. Comparable as both a BGM peer and a CGM competitor whose portfolio increasingly defines AgaMatrix's strategic direction.

Regional players

• Sinocare Inc. Sinocare is a China-based BGM and POCT device manufacturer with growing international distribution. Comparable on BGM product line and value-tier positioning, primarily serving APAC markets rather than directly competing in AgaMatrix's U.S./EU core.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AgaMatrix
• Facebookfacebook.com/AgaMatrixInc
• LinkedInlinkedin.com/company/agamatrix

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds7 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AgaMatrix